Sato, Motoya
Tamura, Yoshiaki
Murao, Yuji
Yorikawa, Fumino
Katsumata, Yuu
Watanabe, So
Zen, Shugo
Kodera, Remi
Oba, Kazuhito
Toyoshima, Kenji
Chiba, Yuko
Araki, Atsushi
Article History
Received: 8 January 2023
Accepted: 24 September 2023
First Online: 22 November 2023
Declarations
:
: This study was conducted in accordance with the Declaration of Helsinki, and the study protocol was approved by the Ethics Review Committee of Tokyo Metropolitan Geriatric Hospital (R21-012). Since the Ethics Committee of Tokyo Metropolitan Geriatric Hospital (R21-012) determined that written patient consent was not required, the study was conducted using an opt-out method, and informed consent was not obtained directly from the participants.
: Not applicable.
: Araki A received speaker honoraria from Merck Sharp & Dohme, Sumitomo Pharma Co. Ltd., Ono Pharmaceutical Co. Ltd., Takeda Pharmaceutical Co. Ltd., and Novo Nordisk Pharma Ltd. The other authors declare that they have no conflicts of interest.